Long-term study in adults with Type 2 diabetes presented at the 45th annual meeting of the European Association for the Study of Diabetes.
Read More »Yearly Archives: 2009
EASD: Insulin Analogues, Cancer Linked, but No Causality Shown
Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with other insulins, researchers said.
Read More »EASD: XOMA Presents Novel Mechanism of Action for XOMA 052 in Regulating IL-1 Beta Levels
XOMA, a leader in the discovery and development of therapeutic antibodies, announced new data demonstrating the unique regulatory mechanism of action of XOMA 052, a potent antibody drug candidate that inhibits the inflammatory cytokine interleukin-1 beta (IL-1 beta). XOMA 052 is currently under study for the treatment of patients with …
Read More »Three Inexpensive Drugs Reduce Heart Attack, Stroke Risks by 80%
People who are at high risk of experiencing a heart attack or stroke can reduce their risk by up to 80 percent if they take a combination of three inexpensive drugs, according to a new study.
Read More »Healthy Lifestye Factors Can Reduce Deadly Chronic Diseases by 80%
In the previous article you learned about taking 3 drugs to reduce the risk of heart disease. This study show you how you can do the same thing for free.
Read More »Poor Math Skills Can Worsen Diabetes Control
A new study has shown us that diabetic adults’ ability to work with numbers may affect their management of the disease and that, in turn, may help explain racial differences in diabetes control.
Read More »New Markers Discovered for Early Detection of Type 1 Diabetes
Diabetes can be dangerous — especially when the disease is not diagnosed in time. Scientists have identified new markers which enable an early diagnosis and prognosis of Type 1 diabetes.
Read More »Irregular Heartbeat Risk Higher in Women with Type 2 Diabetes
Women with Type 2 diabetes have a 26 percent increased risk of developing atrial fibrillation, a potentially life-threatening irregular heartbeat, new findings suggest. The reason behind the gender difference isn’t clear, researchers say.
Read More »Diabetes Education Lowers Health Care Costs!
The AADE Education and Research Foundation funded a study of Medicare and commercial member claims which revealed that people with diabetes who received diabetes education have lower average health care costs than patients who do not participate in diabetes education.
Read More »Letter from the Editor #488
This week, the word “pancreatitis” is back in the news, as the FDA suspects that Merck & Co., Inc.’s blockbuster diabetes drug Januvia may be linked to serious cases of pancreatitis. Although many leading endocrinologists including Steve Edelman and Ralph DeFronzo have previously told us that patients with diabetes are …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.